130 related articles for article (PubMed ID: 12383477)
1. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.
Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477
[TBL] [Abstract][Full Text] [Related]
2. Artificial neural network classification based on capillary electrophoresis of urinary nucleosides for the clinical diagnosis of tumors.
Zhao R; Xu G; Yue B; Liebich HM; Zhang Y
J Chromatogr A; 1998 Dec; 828(1-2):489-96. PubMed ID: 9916327
[TBL] [Abstract][Full Text] [Related]
3. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
Seidel P; Seidel A; Herbarth O
Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
[TBL] [Abstract][Full Text] [Related]
4. Urinary nucleosides as potential tumor markers evaluated by learning vector quantization.
Dieterle F; Müller-Hagedorn S; Liebich HM; Gauglitz G
Artif Intell Med; 2003 Jul; 28(3):265-79. PubMed ID: 12927336
[TBL] [Abstract][Full Text] [Related]
5. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.
Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O
Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264
[TBL] [Abstract][Full Text] [Related]
6. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations.
Seidel A; Seidel P; Manuwald O; Herbarth O
Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography].
Zheng YF; Chen YJ; Pang T; Shi XZ; Kong HW; Lü S; Yang Q; Xu GW
Se Pu; 2002 Nov; 20(6):498-501. PubMed ID: 12682995
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
[TBL] [Abstract][Full Text] [Related]
9. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
[TBL] [Abstract][Full Text] [Related]
10. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
11. Urinary nucleosides as biological markers for patients with colorectal cancer.
Zheng YF; Yang J; Zhao XJ; Feng B; Kong HW; Chen YJ; Lv S; Zheng MH; Xu GW
World J Gastroenterol; 2005 Jul; 11(25):3871-6. PubMed ID: 15991285
[TBL] [Abstract][Full Text] [Related]
12. Classification of lung cancer patients and controls by chromatography of modified nucleosides in serum.
McEntire JE; Kuo KC; Smith ME; Stalling DL; Richens JW; Zumwalt RW; Gehrke CW; Papermaster BW
Cancer Res; 1989 Feb; 49(4):1057-62. PubMed ID: 2912551
[TBL] [Abstract][Full Text] [Related]
13. Modified Nucleosides - Molecular Markers Suitable for Small-volume Cancer?
Opitz P; Herbarth O; Seidel A; Boehm A; Fischer M; Mozet C; Dietz A; Wichmann G
Anticancer Res; 2018 Nov; 38(11):6113-6119. PubMed ID: 30396926
[TBL] [Abstract][Full Text] [Related]
14. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
[TBL] [Abstract][Full Text] [Related]
15. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
Struck-Lewicka W; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
[TBL] [Abstract][Full Text] [Related]
16. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients.
Xu G; Liebich HM; Lehmann R; Müller-Hagedorn S
Methods Mol Biol; 2001; 162():459-74. PubMed ID: 11217356
[No Abstract] [Full Text] [Related]
17. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese.
Hsu WY; Chen CJ; Huang YC; Tsai FJ; Jeng LB; Lai CC
PLoS One; 2013; 8(12):e81701. PubMed ID: 24367489
[TBL] [Abstract][Full Text] [Related]
18. A new way to fast and high resolution determination of modified nucleosides.
Studzińska S; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():93-101. PubMed ID: 22309775
[TBL] [Abstract][Full Text] [Related]
19. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients.
Frickenschmidt A; Frohlich H; Bullinger D; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Biomarkers; 2008 Jun; 13(4):435-49. PubMed ID: 18484357
[TBL] [Abstract][Full Text] [Related]
20. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
